Viewing Study NCT00412867


Ignite Creation Date: 2025-12-25 @ 12:45 AM
Ignite Modification Date: 2026-01-06 @ 9:29 AM
Study NCT ID: NCT00412867
Status: COMPLETED
Last Update Posted: 2018-01-19
First Post: 2006-12-17
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Post-marketing Clinical Study of Alteplase for Acute Ischemic Stroke (Japan Alteplase Clinical Trial Ⅱ:J-ACT Ⅱ)
Sponsor: Tanabe Pharma Corporation
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 527-0611
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View